Cited by 21Prostate Cancer Treatment and ResearchGenomic variations and chromosomal abnormalitiesCancer Genomics and Diagnostics

The DOI matches its Crossref record; its reference list is not available.

Karyotypic similarity identified by multiplex‐FISH relates four prostate adenocarcinoma cell lines: PC‐3, PPC‐1, ALVA‐31, and ALVA‐41

Varella‐Garcia, Marileila, Boomer, Theresa, Miller, Gary J.·2001·Genes, Chromosomes and Cancer

Abstract

Recently developed molecular cytogenetic techniques for karyotyping are providing new and important insights regarding the chromosomal changes that occur in solid tumors. We used multiplex-FISH to analyze four adenocarcinoma cell lines, PC-3, PPC-1, ALVA-31, and ALVA-41, in which the characterization of a large number of rearranged chromosomes was partially or substantially inconclusive by G-banding. Although the original descriptions of these lines depict them as distinct entities established from different patients, this study demonstrates that these four lines share numerous, highly rearranged chromosomes, strongly supporting the conclusion that they are derived from the same patient material. Our analysis indicates that PPC-1, ALVA-31, and ALVA-41 were derived from PC-3 through mechanisms involving clonal progression represented by sequential changes and clonal diversion represented by differing patterns of changes. Extensive cellular heterogeneity was detected in all four lines, and most rearrangements included segments derived from multiple chromosomes. Each line also showed a set of unique derivative chromosomes. However, a limited number of metaphase cells (approximately 10) was analyzed for each line, and numerous single-cell abnormalities were detected in all of them. Therefore, it is plausible that the number of clonal, shared, and/or unique rearrangements has been underestimated. These cell lines have been utilized as models for understanding the biology of prosta…

Overview

Integrity signals

Registry

Crossref · 10.1002/gcc.1149

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • ALVA-31 was originally established in 1993 as a human prostate carcinoma, but was found to be identical to PC-3 in 2001.

    “This cell line was originally established in 1993 as a human prostate carcinoma [35], but was found to be identical to a different human prostate carcinoma, the PC-3 cell line, in 2001 [36, 37].”

Citations

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 35 · Cited by 21

Research works printed but not linked: 33

  1. 10.1002/1098-2264(2000)9999:9999<::AID-GCC1076>3.0.CO;2-E · DOI
  2. 10.2165/00066982-200005010-00008 · DOI
  3. 10.1016/S0165-4608(96)00258-0 · DOI
  4. 10.1159/000133283 · DOI
  5. 10.1002/ijc.2910440525 · DOI
  6. 10.1159/000133468 · DOI
  7. 10.3322/canjclin.50.1.7 · DOI
  8. 10.1002/(SICI)1097-0045(19980701)36:2<92::AID-PROS4>3.0.CO;2-G · DOI
  9. 10.1007/978-3-642-60162-0_21 · DOI
  10. ISCN, 1995, Guidelines for cancer cytogenetics: an international system for human cytogenetics nomenclature
  11. Kaighn ME, 1979, Establishment and characterization of a human prostatic carcinoma cell line (PC‐3), Invest Urol, 17, 16
  12. 10.1007/s11626-998-0078-x · DOI
  13. 10.1002/1098-2264(200007)28:3<308::AID-GCC9>3.0.CO;2-B · DOI
  14. 10.1002/pros.2990220202 · DOI · Paper page
  15. Macville M, 1999, Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping, Cancer Res, 59, 141
  16. 10.1016/S0165-4608(98)00142-3 · DOI
  17. Miller GJ, 1995, Vitamin D receptor expression, 24‐hydroxylase activity, and inhibition of growth by 1α, 25‐dihydroxyvitamin D3 in seven human prostatic carcinoma cell lines, Clin Cancer Res, 1, 997
  18. 10.1016/0039-128X(94)90052-3 · DOI
  19. 10.1002/cyto.990100105 · DOI
  20. Ohnuki Y, 1980, Chromosomal analysis of human prostatic adenocarcinoma cell lines, Cancer Res, 40, 524
  21. 10.1002/(SICI)1098-2264(199905)25:1<53::AID-GCC8>3.0.CO;2-T · DOI
  22. 10.1159/000015432 · DOI · Paper page
  23. 10.1002/1098-2264(2000)9999:9999<::AID-GCC1075>3.0.CO;2-H · DOI
  24. 10.1038/sj.neo.7900036 · DOI
  25. Rao PH, 1998, Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma, Blood, 92, 1743
  26. Rowley JD, 1999, Spectral karyotype analysis of T‐cell acute leukemia, Blood, 93, 2038, 10.1182/blood.V93.6.2038.406a32_2038_2042 · DOI
  27. 10.1073/pnas.97.1.303 · DOI
  28. 10.1182/blood.V92.11.4269.423k31_4269_4278 · DOI
  29. 10.1126/science.273.5274.494 · DOI
  30. 10.1038/ng0496-368 · DOI
  31. 10.1002/pros.1045 · DOI · Paper page
  32. 10.1038/ng0497-406 · DOI
  33. 10.1016/S0165-4608(98)00095-8 · DOI

Metadata

Authors
Varella‐Garcia, M., Boomer, T., & Miller, G. J.
Affiliations
University of Colorado Health (US)
Corresponding author
Miller, Gary J.
Venue
Genes, Chromosomes and Cancer
Publisher
Wiley
Published
2001-05-31
Volume
31
Issue
4
Pages
303-315
ISSN
  • 1045-2257 (ISSN-L)
  • 1098-2264
OpenAlex
W2053671546
Cited by
21
References
35
Citations by year
2019: 1 · 2018: 1 · 2017: 1 · 2012: 1
FWCI
3.52
Type
journal article
Language
en
Open access
closed
Locations
  • Genes Chromosomes and Cancer (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01ca053520-06)
  • National Cancer Institute (R01CA084269, CA-53520, CA-84269, CA-46934, P30CA046934)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Keywords
prostate adenocarcinoma, prostate cancer cell lines, PC-3 cells, clonal evolution, chromosomal rearrangements, derivative chromosomes, cellular heterogeneity, cell line derivation, multiplex FISH
MeSH terms
Adenocarcinoma, Chromosome Aberrations, Clone Cells, Genetic Markers, Humans, Karyotyping, Male, Middle Aged, Prostatic Neoplasms, Tumor Cells, Cultured, In Situ Hybridization, Fluorescence, Chromosome Disorders, White People

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review